2011
DOI: 10.1016/j.amjsurg.2010.02.015
|View full text |Cite
|
Sign up to set email alerts
|

A comparative analysis of core needle biopsy and final excision for breast cancer: histology and marker expression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

9
27
3
3

Year Published

2013
2013
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 37 publications
(42 citation statements)
references
References 11 publications
9
27
3
3
Order By: Relevance
“…For p53, the concordance rate was 76.7% in our study, which is similar to the results of Ough et al [15]. Other studies have reported concordance rates of 85-100% [7].…”
Section: Disclosure Statementsupporting
confidence: 82%
See 2 more Smart Citations
“…For p53, the concordance rate was 76.7% in our study, which is similar to the results of Ough et al [15]. Other studies have reported concordance rates of 85-100% [7].…”
Section: Disclosure Statementsupporting
confidence: 82%
“…Ough et al [15] and Arnedos et al [8] reported concordance rates of 78 and 85%, respectively for PR, while this rate was 90% in our study. Furthermore, our results showed a higher sensitivity (93.7%) and specificity (85.7%).…”
Section: Resultscontrasting
confidence: 52%
See 1 more Smart Citation
“…As well, neoadjuvant treatment, when indicated, can be based on the grade assessment and HR status of the CNBS. In cases of complete pathologic response, this will be the only source for evaluation of HR (1, 2). It can also determine the HR status more accurately than the IHC exam of an excised tumor with partial response to neoadjuvant chemotherapy.…”
Section: Discussionmentioning
confidence: 99%
“…In modern practice, the diagnosis of breast cancer is completed through the histological exam of core needle biopsy (CNB) samples(1). One of the important issues in treatment planning is the hormone receptor (HR) status of the tumor which can be assessed by immunohistochemitry (IHC) on the CNB specimens (CNBS) or over the subsequent surgical sample (SS).When neoadjuvant therapies are necessary preoperatively, decision making would necessarily be based on the evaluation of the needle biopsy samples (2).…”
Section: Introductionmentioning
confidence: 99%